IDEAS home Printed from https://ideas.repec.org/a/unt/japsdj/v29y2022i2p47-69.html
   My bibliography  Save this article

Strade Measures On Pharmaceutical Products: Can They Promote Local Production And Public Health?

Author

Listed:
  • Padmashree Gehl Sampath

    (Berkman Klein Center for Internet & Society at Harvard University)

Abstract

The rise in trade measures on pharmaceutical products has become a matter of intense debate since the start of the COVID-19 crisis. By October 2022, more than140 export restrictions had been placed on them worldwide; at least 50 directly affected vaccine production and distribution. A systematic assessment of their welfare effects offers a way to classify the plethora of trade measures in the global pharmaceutical sector with an explanation of their use in different jurisdictions worldwide. It also provides an assessment and indicates advances on ways in which such trade measures can be used in the interest of local production and public health.

Suggested Citation

  • Padmashree Gehl Sampath, 2022. "Strade Measures On Pharmaceutical Products: Can They Promote Local Production And Public Health?," Asia-Pacific Sustainable Development Journal, United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), vol. 29(2), pages 47-69, November.
    • Handle: RePEc:unt:japsdj:v:29:y:2022:i:2:p:47-69
    as

    Download full text from publisher

    File URL: https://www.unescap.org/sites/default/d8files/2022-11/APSDJ%20Vol.%2029%2C%20No.%202_pp%2047-69.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Andrea Andrenelli & Julien Gourdon & Evdokia Moïsé, 2019. "International Technology Transfer Policies," OECD Trade Policy Papers 222, OECD Publishing.
    2. Helble, Matthias & Shepherd, Benjamin, 2017. "Trade in Health Products: Reducing Trade Barriers for Better Health," ADBI Working Papers 643, Asian Development Bank Institute.
    3. Vincent Ahonkhai & Samuel F Martins & Alexandre Portet & Murray Lumpkin & Dan Hartman, 2016. "Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers DT/2024/01, DIAL (Développement, Institutions et Mondialisation).
    2. Anand Sharma & Vipin Sharma & Shekhar Tokas, 2022. "Institutional quality and health outcomes: evidence from the EU countries," Economics and Business Letters, Oviedo University Press, vol. 11(2), pages 70-78.
    3. Ayona Bhattacharjee & Rupa Chanda, 2023. "Trade in health products and population health: A long‐run relation," The World Economy, Wiley Blackwell, vol. 46(1), pages 182-207, January.
    4. Steven G Morgan & Brandon Yau & Murray M Lumpkin, 2017. "The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-10, August.
    5. Nilubon Subsittipong & Junjeong Choi & Tae Hyun Kim & Euna Han, 2022. "Delay in Vaccine Access in ASEAN Countries," IJERPH, MDPI, vol. 19(7), pages 1-13, March.
    6. K. Buysse & D. Essers, 2019. "Cheating tiger, tech-savvy dragon : Are Western concerns about “unfair trade” and “Made in China 2025” justified ?," Economic Review, National Bank of Belgium, issue ii, pages 47-70, September.
    7. Chad P. Bown, 2019. "The 2018 US-China Trade Conflict after 40 Years of Special Protection," Working Paper Series WP19-7, Peterson Institute for International Economics.
    8. Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers 2024-02, CEPII research center.
    9. Ria Christine Siagian & Dumilah Ayuningtyas, 2019. "Gap analysis for drug development policy-making: An attempt to close the gap between policy and its implementation," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-13, August.
    10. Robert W. Ciborowski & Iwona Skrodzka, 2019. "International Technology Transfer, Innovation and Economic Development of European Union Countries in 2008-2017," European Research Studies Journal, European Research Studies Journal, vol. 0(3), pages 384-404.

    More about this item

    Keywords

    local production; trade measures; tariffs; non-tariff measures; industrial policy; access to medicines; government policy; intellectual property rights;
    All these keywords.

    JEL classification:

    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
    • I15 - Health, Education, and Welfare - - Health - - - Health and Economic Development
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • L11 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Production, Pricing, and Market Structure; Size Distribution of Firms
    • L23 - Industrial Organization - - Firm Objectives, Organization, and Behavior - - - Organization of Production
    • L52 - Industrial Organization - - Regulation and Industrial Policy - - - Industrial Policy; Sectoral Planning Methods
    • O25 - Economic Development, Innovation, Technological Change, and Growth - - Development Planning and Policy - - - Industrial Policy
    • O34 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
    • O38 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Government Policy

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:unt:japsdj:v:29:y:2022:i:2:p:47-69. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Office of the Executive Secretary, ESCAP (email available below). General contact details of provider: https://edirc.repec.org/data/escapth.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.